Literature DB >> 19821102

The association between RASSF1 gene polymorphisms and lung cancer susceptibility among people in Hubei Province of China.

Geqiong Xiao1, Tao Zhang, Jie Yao, Jinghua Ren, Wenmiao Cao, Gang Wu.   

Abstract

The relationship between Ala/Ser polymorphism in 133 codon of exon 3 region of the RASSF1 gene and genetic susceptibility of lung cancer in Hubei province Han population was investigated by a case-control study. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique was adopted to analyze the polymorphism of codon 133 of exon 3 in the RASSF1 gene of 100 pathologically diagnosed lung cancer patients, and 100 healthy controls. The relationship between different genotypes and the susceptibility of lung cancer was analyzed. Among 200 blood samples from Han people in Hubei Province, including 100 from lung cancer patients and 100 from healthy controls, the frequencies of Ala/Ala, Ala/Ser, Ser/Ser genotype of the RASSF1 in lung cancer patients were 83%, 16%, 1%, and those in healthy controls was 93%, 7%, 0% respectively, with the difference being statistically significant between two groups (P<0.05). The individuals with Ala/Ser genotype had higher risk of suffering from lung cancer, with an OR of 2.341, and 95% CI of 1.009-6.393 respectively. It was concluded that RASSF1Ala133Ser was a susceptible genetic factor of lung cancer. Ala/Ser genotype increased the risk of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19821102     DOI: 10.1007/s11596-009-0522-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  17 in total

1.  The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1.

Authors:  Sara Ortiz-Vega; Andrei Khokhlatchev; Maria Nedwidek; Xian-feng Zhang; Reinhard Dammann; Gerd P Pfeifer; Joseph Avruch
Journal:  Oncogene       Date:  2002-02-21       Impact factor: 9.867

2.  Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases.

Authors:  A Premzl; V Puizdar; V Zavasnik-Bergant; N Kopitar-Jerala; T T Lah; N Katunuma; B F Sloane; V Turk; J Kos
Journal:  Biol Chem       Date:  2001-05       Impact factor: 3.915

3.  Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.

Authors:  Mei Y Yu; Joanna H M Tong; Paul K S Chan; Tin L Lee; Michael W Y Chan; Anthony W H Chan; Kwok W Lo; Kai F To
Journal:  Int J Cancer       Date:  2003-06-10       Impact factor: 7.396

4.  Identification of a novel Ras-regulated proapoptotic pathway.

Authors:  Andrei Khokhlatchev; Shahrooz Rabizadeh; Ramnik Xavier; Maria Nedwidek; Tao Chen; Xian-feng Zhang; Brian Seed; Joseph Avruch
Journal:  Curr Biol       Date:  2002-02-19       Impact factor: 10.834

5.  Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression.

Authors:  D G Burbee; E Forgacs; S Zöchbauer-Müller; L Shivakumar; K Fong; B Gao; D Randle; M Kondo; A Virmani; S Bader; Y Sekido; F Latif; S Milchgrub; S Toyooka; A F Gazdar; M I Lerman; E Zabarovsky; M White; J D Minna
Journal:  J Natl Cancer Inst       Date:  2001-05-02       Impact factor: 13.506

6.  RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.

Authors:  Hideki Endoh; Yasushi Yatabe; Shigeki Shimizu; Kohei Tajima; Hiroyuki Kuwano; Takashi Takahashi; Tetsuya Mitsudomi
Journal:  Int J Cancer       Date:  2003-08-10       Impact factor: 7.396

7.  RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1.

Authors:  Stella Tommasi; Reinhard Dammann; Seung-Gi Jin; Xian-feng Zhang; Joseph Avruch; Gerd P Pfeifer
Journal:  Oncogene       Date:  2002-04-18       Impact factor: 9.867

8.  Relationship of Ras association domain family 1 methylation and K-ras mutation in primary non-small cell lung cancer.

Authors:  Duk-Hwan Kim; Jin Seuk Kim; Jung-Ho Park; Suk Kyoo Lee; Yong-Ick Ji; Young Mi Kwon; Young Mog Shim; Joungho Han; Joobae Park
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

9.  Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma.

Authors:  Angelo Agathanggelou; Ivan Bièche; Jalal Ahmed-Choudhury; Barbara Nicke; Reinhard Dammann; Shairaz Baksh; Boning Gao; John D Minna; Julian Downward; Eamonn R Maher; Farida Latif
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

10.  The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex.

Authors:  Min Sup Song; Su Jeong Song; Nagi G Ayad; Jin Sook Chang; Joo Hyun Lee; Hyun Kyung Hong; Ho Lee; Naeyun Choi; Jhingook Kim; Hojoong Kim; Jin Woo Kim; Eui-Ju Choi; Marc W Kirschner; Dae-Sik Lim
Journal:  Nat Cell Biol       Date:  2004-01-25       Impact factor: 28.824

View more
  2 in total

1.  A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.

Authors:  Karen S Yee; Lukasz Grochola; Garth Hamilton; Anna Grawenda; Elisabeth E Bond; Helge Taubert; Peter Wurl; Gareth L Bond; Eric O'Neill
Journal:  Cancer Res       Date:  2012-03-02       Impact factor: 12.701

2.  The Association of Ala133Ser Polymorphism and Methylation in Ras Association Domain Family 1A Gene With Unfavorable Prognosis of Hepatocellular Carcinoma.

Authors:  Ying Feng; Peng Li; Yifei Liu; Zhenyu Sha; Liang Feng; Fei Wang; Qinsheng Mao; Wanjiang Xue
Journal:  Hepat Mon       Date:  2015-10-28       Impact factor: 0.660

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.